1. A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients. (26th May 2017) Authors: Schindler, E; Amantea, MA; Karlsson, MO; Friberg, LE Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 6(2017) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Review of Mixed‐Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis. (7th May 2014) Authors: Ribba, B; Holford, NH; Magni, P; Trocóniz, I; Gueorguieva, I; Girard, P; Sarr, C; Elishmereni, M; Kloft, C; Friberg, LE Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 5(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014). (19th July 2017) Authors: Musuamba, FT; Manolis, E; Holford, N; Cheung, SYA; Friberg, LE; Ogungbenro, K; Posch, M; Yates, JWT; Berry, S; Thomas, N; Corriol‐Rohou, S; Bornkamp, B; Bretz, F; Hooker, AC; Van der Graaf, PH; Standing, JF; Hay, J; Cole, S; Gigante, V; Karlsson, K Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 7(2017) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CPT: Pharmacometrics & Systems Pharmacology Publishes Its 100th Article. (March 2014) Authors: van der Graaf, PH; Friberg, LE Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 3(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia. (13th July 2017) Authors: Krekels, EHJ; Novakovic, AM; Vermeulen, AM; Friberg, LE; Karlsson, MO Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 8(2017) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities. Issue 1 (9th December 2014) Authors: Venkatakrishnan, K; Friberg, LE; Ouellet, D; Mettetal, JT; Stein, A; Trocóniz, IF; Bruno, R; Mehrotra, N; Gobburu, J; Mould, DR Journal: Clinical pharmacology & therapeutics Issue: Volume 97:Issue 1(2015:Jan.) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib‐Treated Patients With Gastrointestinal Stromal Tumors. (30th May 2017) Authors: Schindler, E; Krishnan, SM; Mathijssen, RHJ; Ruggiero, A; Schiavon, G; Friberg, LE Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 7(2017) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacometrics and Systems Pharmacology Software Tutorials and Use: Comments and Guidelines for PSP Contributions. (18th December 2013) Authors: Vicini, P; Friberg, LE; van der Graaf, PH; Rostami‐Hodjegan, A Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 12(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib‐Treated Patients With GIST. (4th December 2013) Authors: Hansson, EK; Ma, G; Amantea, MA; French, J; Milligan, PA; Friberg, LE; Karlsson, MO Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 12(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PKPD Modeling of VEGF, sVEGFR‐2, sVEGFR‐3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GIST. (20th November 2013) Authors: Hansson, EK; Amantea, MA; Westwood, P; Milligan, PA; Houk, BE; French, J; Karlsson, MO; Friberg, LE Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 11(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗